Gyeonggi-do, South Korea

Yong Gyu Son

This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Gyu Son. Retrieved from https://idiyas.com/inventor/yong-gyu-son-ell4rf68

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong Gyu Son: Innovator in Bispecific Antibodies

Introduction

Yong Gyu Son is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work has the potential to advance therapeutic options in various medical applications.

Latest Patents

Yong Gyu Son holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This patent represents a crucial step in the development of targeted therapies that can enhance the immune response against cancer cells.

Career Highlights

Currently, Yong Gyu Son is associated with Abl Bio Inc., a company dedicated to advancing biopharmaceuticals. His role at Abl Bio Inc. allows him to collaborate with other talented professionals in the field, driving innovation and research forward.

Collaborations

Some of his notable coworkers include Kyung Jin Park and Yang Soon Lee. Their combined expertise contributes to the success of their projects and the advancement of their research initiatives.

Conclusion

Yong Gyu Son's work in bispecific antibodies exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…